
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Development of a Plasma Screening Panel for Pediatric Nonalcoholic Fatty Liver Disease Using Metabolomics
Richard D. Khusial, Catherine E. Cioffi, Shelley Caltharp, et al.
Hepatology Communications (2019) Vol. 3, Iss. 10, pp. 1311-1321
Open Access | Times Cited: 44
Richard D. Khusial, Catherine E. Cioffi, Shelley Caltharp, et al.
Hepatology Communications (2019) Vol. 3, Iss. 10, pp. 1311-1321
Open Access | Times Cited: 44
Showing 1-25 of 44 citing articles:
Perfluoroalkyl substances and severity of nonalcoholic fatty liver in Children: An untargeted metabolomics approach
Ran Jin, Rob McConnell, Catherine E. Cioffi, et al.
Environment International (2019) Vol. 134, pp. 105220-105220
Open Access | Times Cited: 175
Ran Jin, Rob McConnell, Catherine E. Cioffi, et al.
Environment International (2019) Vol. 134, pp. 105220-105220
Open Access | Times Cited: 175
Machine Learning in Nutrition Research
Daniel Kirk, E.J. Kok, Michele Tufano, et al.
Advances in Nutrition (2022) Vol. 13, Iss. 6, pp. 2573-2589
Open Access | Times Cited: 71
Daniel Kirk, E.J. Kok, Michele Tufano, et al.
Advances in Nutrition (2022) Vol. 13, Iss. 6, pp. 2573-2589
Open Access | Times Cited: 71
Prenatal Exposure to Perfluoroalkyl Substances Associated With Increased Susceptibility to Liver Injury in Children
Nikos Stratakis, David V. Conti, Ran Jin, et al.
Hepatology (2020) Vol. 72, Iss. 5, pp. 1758-1770
Open Access | Times Cited: 132
Nikos Stratakis, David V. Conti, Ran Jin, et al.
Hepatology (2020) Vol. 72, Iss. 5, pp. 1758-1770
Open Access | Times Cited: 132
The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease
Nikolaos Perakakis, Konstantinos Stefanakis, Christos S. Mantzoros
Metabolism (2020) Vol. 111, pp. 154320-154320
Open Access | Times Cited: 124
Nikolaos Perakakis, Konstantinos Stefanakis, Christos S. Mantzoros
Metabolism (2020) Vol. 111, pp. 154320-154320
Open Access | Times Cited: 124
Non-alcoholic fatty liver disease and childhood obesity
Meera Shaunak, Christopher D. Byrne, Nikki Davis, et al.
Archives of Disease in Childhood (2020) Vol. 106, Iss. 1, pp. 3-8
Open Access | Times Cited: 96
Meera Shaunak, Christopher D. Byrne, Nikki Davis, et al.
Archives of Disease in Childhood (2020) Vol. 106, Iss. 1, pp. 3-8
Open Access | Times Cited: 96
Identification of Gut Microbial Lysine and Histidine Degradation and CYP-Dependent Metabolites as Biomarkers of Fatty Liver Disease
Anastasiia Driuchina, Jukka Hintikka, Marko Lehtonen, et al.
mBio (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 23
Anastasiia Driuchina, Jukka Hintikka, Marko Lehtonen, et al.
mBio (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 23
Artificial intelligence applied to ‘omics data in liver disease: towards a personalised approach for diagnosis, prognosis and treatment
Soumita Ghosh, Xun Zhao, Mouaid Alim, et al.
Gut (2024), pp. gutjnl-331740
Open Access | Times Cited: 9
Soumita Ghosh, Xun Zhao, Mouaid Alim, et al.
Gut (2024), pp. gutjnl-331740
Open Access | Times Cited: 9
Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy
Diren Beyoğlu, Jeffrey R. Idle
Metabolites (2020) Vol. 10, Iss. 2, pp. 50-50
Open Access | Times Cited: 69
Diren Beyoğlu, Jeffrey R. Idle
Metabolites (2020) Vol. 10, Iss. 2, pp. 50-50
Open Access | Times Cited: 69
Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes
Serena Scapaticci, Ebe D’Adamo, Angelika Mohn, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 53
Serena Scapaticci, Ebe D’Adamo, Angelika Mohn, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 53
Perspectives on youth‐onset nonalcoholic fatty liver disease
Eduardo Castillo‐Leon, Catherine E. Cioffi, Miriam B. Vos
Endocrinology Diabetes & Metabolism (2020) Vol. 3, Iss. 4
Open Access | Times Cited: 40
Eduardo Castillo‐Leon, Catherine E. Cioffi, Miriam B. Vos
Endocrinology Diabetes & Metabolism (2020) Vol. 3, Iss. 4
Open Access | Times Cited: 40
Comparative study of the anti-obesity effects of white tea and dark tea: Insights from microbiome and metabolomics
Fang Zhou, Bohao Shang, Changwei Liu, et al.
Food Research International (2025) Vol. 202, pp. 115666-115666
Closed Access
Fang Zhou, Bohao Shang, Changwei Liu, et al.
Food Research International (2025) Vol. 202, pp. 115666-115666
Closed Access
Diet, exercise, and supplements: what is their role in the management of the metabolic dysfunction-associated steatotic liver disease in children?
Anastasios Serbis, Stergios A. Pοlyzos, Stavroula Α. Paschou, et al.
Endocrine (2024) Vol. 85, Iss. 3, pp. 988-1006
Open Access | Times Cited: 4
Anastasios Serbis, Stergios A. Pοlyzos, Stavroula Α. Paschou, et al.
Endocrine (2024) Vol. 85, Iss. 3, pp. 988-1006
Open Access | Times Cited: 4
Changes of microbial and metabolome of the equine hindgut during oligofructose-induced laminitis
Maimaiti Tuniyazi, Junying He, Jian Guo, et al.
BMC Veterinary Research (2021) Vol. 17, Iss. 1
Open Access | Times Cited: 26
Maimaiti Tuniyazi, Junying He, Jian Guo, et al.
BMC Veterinary Research (2021) Vol. 17, Iss. 1
Open Access | Times Cited: 26
Microbiome-Based Metabolic Therapeutic Approaches in Alcoholic Liver Disease
Ji Ye Hyun, Seul Ki Kim, Sang Jun Yoon, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8749-8749
Open Access | Times Cited: 16
Ji Ye Hyun, Seul Ki Kim, Sang Jun Yoon, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8749-8749
Open Access | Times Cited: 16
Validation of a screening panel for pediatric metabolic dysfunction–associated steatotic liver disease using metabolomics
Helaina Huneault, A. Gent, Catherine C. Cohen, et al.
Hepatology Communications (2024) Vol. 8, Iss. 3
Open Access | Times Cited: 3
Helaina Huneault, A. Gent, Catherine C. Cohen, et al.
Hepatology Communications (2024) Vol. 8, Iss. 3
Open Access | Times Cited: 3
Exposure to a PFOA, PFOS and PFHxS Mixture during Gestation and Lactation Alters the Liver Proteome in Offspring of CD-1 Mice
Emily Kaye, Emily Marques, Juliana Agudelo Areiza, et al.
Toxics (2024) Vol. 12, Iss. 5, pp. 348-348
Open Access | Times Cited: 3
Emily Kaye, Emily Marques, Juliana Agudelo Areiza, et al.
Toxics (2024) Vol. 12, Iss. 5, pp. 348-348
Open Access | Times Cited: 3
Metabolomic Predictors of Non-alcoholic Steatohepatitis and Advanced Fibrosis in Children
Kattayoun Kordy, Fan Li, David Lee, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 21
Kattayoun Kordy, Fan Li, David Lee, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 21
Non-Alcoholic Fatty Liver Disease in Children
Jernej Brecelj, Rok Orel
Medicina (2021) Vol. 57, Iss. 7, pp. 719-719
Open Access | Times Cited: 20
Jernej Brecelj, Rok Orel
Medicina (2021) Vol. 57, Iss. 7, pp. 719-719
Open Access | Times Cited: 20
Uncovering the roles of dihydropyrimidine dehydrogenase in fatty-acid induced steatosis using human cellular models
Kelly Sullivan, Sheetal Kumar, Xin Liu, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 13
Kelly Sullivan, Sheetal Kumar, Xin Liu, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 13
Pediatric MASLD: current understanding and practical approach
Anne-Sophie R. Stroes, Miriam B. Vos, Marc A. Benninga, et al.
European Journal of Pediatrics (2024) Vol. 184, Iss. 1
Closed Access | Times Cited: 2
Anne-Sophie R. Stroes, Miriam B. Vos, Marc A. Benninga, et al.
European Journal of Pediatrics (2024) Vol. 184, Iss. 1
Closed Access | Times Cited: 2
Amino Acid-Related Metabolic Signature in Obese Children and Adolescents
Nella Polidori, E Grasso, Francesco Chiarelli, et al.
Nutrients (2022) Vol. 14, Iss. 7, pp. 1454-1454
Open Access | Times Cited: 11
Nella Polidori, E Grasso, Francesco Chiarelli, et al.
Nutrients (2022) Vol. 14, Iss. 7, pp. 1454-1454
Open Access | Times Cited: 11
Defining NASH from a Multi-Omics Systems Biology Perspective
Lili Niu, Karolina Sulek, Catherine G. Vasilopoulou, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 20, pp. 4673-4673
Open Access | Times Cited: 13
Lili Niu, Karolina Sulek, Catherine G. Vasilopoulou, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 20, pp. 4673-4673
Open Access | Times Cited: 13
Differences among patients with and without nonalcoholic fatty liver disease having elevated alanine aminotransferase levels at various stages of metabolic syndrome
Masahiro Sogabe, Toshiya Okahisa, Takeshi Kurihara, et al.
PLoS ONE (2020) Vol. 15, Iss. 8, pp. e0238388-e0238388
Open Access | Times Cited: 14
Masahiro Sogabe, Toshiya Okahisa, Takeshi Kurihara, et al.
PLoS ONE (2020) Vol. 15, Iss. 8, pp. e0238388-e0238388
Open Access | Times Cited: 14
Plasma Metabolome Alterations Associated with Extrauterine Growth Restriction
Danuta Dudzik, Isabel Iglesias‐Platas, Montserrat Izquierdo Renau, et al.
Nutrients (2020) Vol. 12, Iss. 4, pp. 1188-1188
Open Access | Times Cited: 13
Danuta Dudzik, Isabel Iglesias‐Platas, Montserrat Izquierdo Renau, et al.
Nutrients (2020) Vol. 12, Iss. 4, pp. 1188-1188
Open Access | Times Cited: 13
Deep Learning of Dual Plasma Fingerprints for High‐Performance Infection Classification
Jing Cao, Yan Xiao, Mengji Zhang, et al.
Small (2022) Vol. 19, Iss. 7
Closed Access | Times Cited: 8
Jing Cao, Yan Xiao, Mengji Zhang, et al.
Small (2022) Vol. 19, Iss. 7
Closed Access | Times Cited: 8